Understood. That’s my view. I think it is logical, and fits my understanding of the regulation and facts. I do not see how it can hurt. I think there will be people claiming it hurts, but that does not fit the facts, the regulatory imperative on the FDA to get it right, or the facts we believe are shown in the trial for those who lived the longest, who now appear to be the core of the new definition of Glioblastoma. I have yet to see a rational suggestion that it will “hurt”.
Market Data 
Markets 
AI
